U.S. authorities have approved the first generic nasal spray edition of Narcan, a drug that reverses opioid overdoses.
The Food and Drug Administration on Friday naloxone spray from Israel’s Teva Pharmaceuticals.
Naloxone has been sold as a nasal spray at the U.S. since 2016 under the new name Narcan. It can be dispensed by pharmacists without a prescription. It’s also sold as a brand-name or generic drug in vials, prefilled syringes and automatic injectors.
More than 47,600 Americans died in 2017, a cost that has been climbing for two decades.